Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass.

Binglin YuanXiqiang HuangJunlin WenMengzhe Peng

Published in: Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia (2024)

The study suggests that 0.50 µg/kg Dex pretreatment could reduce propofol use and the duration of mechanical ventilation, and confer myocardial protection without increased adverse events during cardiac valve replacement.

Keyphrases

mechanical ventilation
left ventricular
acute respiratory distress syndrome
mitral valve
aortic stenosis
intensive care unit
aortic valve
patients undergoing
respiratory failure
extracorporeal membrane oxygenation
cardiac surgery
transcatheter aortic valve replacement